Myelodysplastic syndromes.

Phuong L. Nguyen, Yin Xu, Aminah Jatoi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders in which there is ineffective hematopoiesis. Affected patients are primarily elderly people, but also at risk are certain subsets of patients who have been exposed to antineoplastic chemotherapy and select patients with primary bone marrow failure syndromes such as Fanconi anemia or aplastic anemia. The diagnosis of myelodysplastic syndrome implies a certain probability of leukemic evolution, but the magnitude of this probability varies greatly among patients. Over the years there have been several diagnostic and prognostic classifications of these disorders in an attempt to achieve diagnostic accuracy that is biologically and clinically meaningful. With the aging of the population and with improved survival among patients with cancer, pathologists are likely to confront myelodysplastic syndromes more frequently in their practice. This review discusses the clinical and pathologic manifestations of this group of disorders, major diagnostic and prognostic classification systems, pathogenesis, and select issues that might be clinically relevant in the future.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Pathology
Volume120 Suppl
StatePublished - Dec 2003
Externally publishedYes

Fingerprint

Myelodysplastic Syndromes
Fanconi Anemia
Aplastic Anemia
Hematopoiesis
Hematopoietic Stem Cells
Antineoplastic Agents
Drug Therapy
Survival
Population
Neoplasms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Myelodysplastic syndromes. / Nguyen, Phuong L.; Xu, Yin; Jatoi, Aminah.

In: American Journal of Clinical Pathology, Vol. 120 Suppl, 12.2003.

Research output: Contribution to journalArticle

Nguyen, Phuong L. ; Xu, Yin ; Jatoi, Aminah. / Myelodysplastic syndromes. In: American Journal of Clinical Pathology. 2003 ; Vol. 120 Suppl.
@article{2e791885becb40b9aef82561b7a7864f,
title = "Myelodysplastic syndromes.",
abstract = "Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders in which there is ineffective hematopoiesis. Affected patients are primarily elderly people, but also at risk are certain subsets of patients who have been exposed to antineoplastic chemotherapy and select patients with primary bone marrow failure syndromes such as Fanconi anemia or aplastic anemia. The diagnosis of myelodysplastic syndrome implies a certain probability of leukemic evolution, but the magnitude of this probability varies greatly among patients. Over the years there have been several diagnostic and prognostic classifications of these disorders in an attempt to achieve diagnostic accuracy that is biologically and clinically meaningful. With the aging of the population and with improved survival among patients with cancer, pathologists are likely to confront myelodysplastic syndromes more frequently in their practice. This review discusses the clinical and pathologic manifestations of this group of disorders, major diagnostic and prognostic classification systems, pathogenesis, and select issues that might be clinically relevant in the future.",
author = "Nguyen, {Phuong L.} and Yin Xu and Aminah Jatoi",
year = "2003",
month = "12",
language = "English (US)",
volume = "120 Suppl",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",

}

TY - JOUR

T1 - Myelodysplastic syndromes.

AU - Nguyen, Phuong L.

AU - Xu, Yin

AU - Jatoi, Aminah

PY - 2003/12

Y1 - 2003/12

N2 - Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders in which there is ineffective hematopoiesis. Affected patients are primarily elderly people, but also at risk are certain subsets of patients who have been exposed to antineoplastic chemotherapy and select patients with primary bone marrow failure syndromes such as Fanconi anemia or aplastic anemia. The diagnosis of myelodysplastic syndrome implies a certain probability of leukemic evolution, but the magnitude of this probability varies greatly among patients. Over the years there have been several diagnostic and prognostic classifications of these disorders in an attempt to achieve diagnostic accuracy that is biologically and clinically meaningful. With the aging of the population and with improved survival among patients with cancer, pathologists are likely to confront myelodysplastic syndromes more frequently in their practice. This review discusses the clinical and pathologic manifestations of this group of disorders, major diagnostic and prognostic classification systems, pathogenesis, and select issues that might be clinically relevant in the future.

AB - Myelodysplastic syndromes are a group of clonal hematopoietic stem cell disorders in which there is ineffective hematopoiesis. Affected patients are primarily elderly people, but also at risk are certain subsets of patients who have been exposed to antineoplastic chemotherapy and select patients with primary bone marrow failure syndromes such as Fanconi anemia or aplastic anemia. The diagnosis of myelodysplastic syndrome implies a certain probability of leukemic evolution, but the magnitude of this probability varies greatly among patients. Over the years there have been several diagnostic and prognostic classifications of these disorders in an attempt to achieve diagnostic accuracy that is biologically and clinically meaningful. With the aging of the population and with improved survival among patients with cancer, pathologists are likely to confront myelodysplastic syndromes more frequently in their practice. This review discusses the clinical and pathologic manifestations of this group of disorders, major diagnostic and prognostic classification systems, pathogenesis, and select issues that might be clinically relevant in the future.

UR - http://www.scopus.com/inward/record.url?scp=4043129035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043129035&partnerID=8YFLogxK

M3 - Article

C2 - 15298141

AN - SCOPUS:4043129035

VL - 120 Suppl

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

ER -